Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lung Capacity01:47

Lung Capacity

56.1K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.1K
Pleura of the Lungs01:13

Pleura of the Lungs

6.6K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
6.6K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

984
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
984
Gross Anatomy of the Lungs01:17

Gross Anatomy of the Lungs

4.4K
The lungs are a pair of vital organs connected to the trachea via the left and right bronchi. The base of these organs meets the dome-shaped muscle known as the diaphragm. Encased by the pleurae, the lungs contact the mediastinum. The right lung is shorter yet wider, and has a larger volume than the left lung. The left lung has an indentation known as the cardiac notch. The superior region of the lungs is referred to as the apex, whereas the base is the lower region near the diaphragm. The...
4.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

479
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
479

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.

American journal of respiratory and critical care medicine·2026
Same author

Design of a randomized controlled trial comparing hybrid care with standard care for people with pulmonary fibrosis.

Respiratory research·2026
Same author

Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trial.

Annals of the rheumatic diseases·2026
Same author

[Diagnosis and management of pulmonary sarcoidosis].

Nederlands tijdschrift voor geneeskunde·2026
Same author

Immunological mechanisms and therapeutic approaches in pulmonary fibrosis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial.

The European respiratory journal·2026

Related Experiment Video

Updated: Jan 21, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K

Cough, an unresolved problem in interstitial lung diseases.

Mirjam J G van Manen1, Marlies S Wijsenbeek

  • 1Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.

Current Opinion in Supportive and Palliative Care
|August 1, 2019
PubMed
Summary

Chronic cough in interstitial lung diseases (ILDs) significantly impacts patient wellbeing. While new treatments like sodium cromoglycate show promise for idiopathic pulmonary fibrosis (IPF), effective therapies remain elusive.

More Related Videos

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

1.1K
Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
05:43

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

1.2K

Related Experiment Videos

Last Updated: Jan 21, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K
Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

1.1K
Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
05:43

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

1.2K

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Research

Background:

  • Chronic cough is a prevalent and debilitating symptom in patients with interstitial lung diseases (ILDs), particularly fibrotic ILDs.
  • The underlying mechanisms of cough in ILDs are not well understood, and current treatments offer limited efficacy.
  • The significant impact of cough on patients' physical and psychological wellbeing necessitates the development of effective therapies.

Purpose of the Study:

  • To review recent advancements in understanding and treating chronic cough in interstitial lung diseases (ILDs).
  • To highlight emerging therapeutic strategies and their potential impact on patient quality of life.

Main Methods:

  • Review of recent scientific literature focusing on cough in ILDs.
  • Analysis of proof-of-concept studies and observational data for novel treatments.
  • Evaluation of existing therapeutic approaches, including acid inhibition.

Main Results:

  • Nebulized sodium cromoglycate demonstrated a promising effect in a proof-of-concept study for idiopathic pulmonary fibrosis (IPF)-related cough.
  • Observational data suggest potential cough reduction with the antifibrotic agent pirfenidone in IPF.
  • Studies investigating acid inhibition for ILD-related cough have yielded contradictory results.

Conclusions:

  • Initial steps toward new treatment options for chronic cough in ILDs, especially IPF, are being explored.
  • Despite promising preliminary findings, an effective and widely applicable antitussive therapy for ILD-associated cough is still lacking.
  • Further research is crucial to elucidate cough pathophysiology and develop targeted, effective treatments for patients with ILDs.